Wissner A, Berger D M, Boschelli D H, Floyd M B, Greenberger L M, Gruber B C, Johnson B D, Mamuya N, Nilakantan R, Reich M F, Shen R, Tsou H R, Upeslacis E, Wang Y F, Wu B, Ye F, Zhang N
Wyeth-Ayerst Research, A Division of American Home Products, 401 North Middletown Road, Pearl River, New York 10965-1215, USA.
J Med Chem. 2000 Aug 24;43(17):3244-56. doi: 10.1021/jm000206a.
The synthesis and SAR of a series of 4-anilino-6, 7-dialkoxyquinoline-3-carbonitrile inhibitors of epidermal growth factor receptor (EGF-R) kinase are described. Condensation of 3, 4-dialkoxyanilines with ethyl (ethoxymethylene)cyanoacetate followed by thermal cyclization gave, regiospecifically, 6,7-dialkoxy-4-oxo-1, 4-dihydroquinoline-3-carbonitriles. Chlorination (POCl(3)) followed by the reaction with substituted anilines furnished the 4-anilino-6, 7-dialkoxyquinoline-3-carbonitrile inhibitors of EGF-R kinase. An alternate synthesis of these compounds starts with a methyl 3, 4-dialkoxybenzoate. Nitration followed by reduction (Fe, NH(4)Cl, MeOH-H(2)O) gave a methyl 2-amino-4,5-dialkoxybenzoate. Amidine formation using DMF-acetal followed by cyclization using LiCH(2)CN furnished a 6,7-dialkoxy-4-oxo-1,4-dihydroquinoline-3-carbonitrile, which was transformed as before. Compounds containing acid, ester, amide, carbinol, and aldehyde groups at the 3-position of the quinoline ring were also prepared for comparison, as were several 1-anilino-6,7-dimethoxyisoquinoline-4-carbonitriles. The compounds were evaluated for their ability to inhibit the autophosphorylation of the catalytic domain of EGF-R. The SAR of these inhibitors with respect to the nature of the 6,7-alkoxy groups, the aniline substituents, and the substituent at the 3-position was studied. The compounds were further evaluated for their ability to inhibit the growth of cell lines that overexpress EGF-R or HER-2. It was found that 4-anilinoquinoline-3-carbonitriles are effective inhibitors of EGF-R kinase with activity comparable to the 4-anilinoquinazoline-based inhibitors. A new homology model of EGF-R kinase was constructed based on the X-ray structures of Hck and FGF receptor-1 kinase. The model suggests that with the quinazoline-based inhibitors, the N3 atom is hydrogen-bonded to a water molecule which, in turn, interacts with Thr 830. It is proposed that the quinoline-3-carbonitriles bind in a similar manner where the water molecule is displaced by the cyano group which interacts with the same Thr residue.
本文描述了一系列表皮生长因子受体(EGF-R)激酶的4-苯胺基-6,7-二烷氧基喹啉-3-腈抑制剂的合成及其构效关系(SAR)。3,4-二烷氧基苯胺与(乙氧基亚甲基)氰基乙酸乙酯缩合,随后热环化,区域特异性地得到6,7-二烷氧基-4-氧代-1,4-二氢喹啉-3-腈。氯化(POCl₃)后与取代苯胺反应,得到EGF-R激酶的4-苯胺基-6,7-二烷氧基喹啉-3-腈抑制剂。这些化合物的另一种合成方法是以3,4-二烷氧基苯甲酸甲酯为起始原料。硝化后还原(Fe、NH₄Cl、甲醇-水)得到2-氨基-4,5-二烷氧基苯甲酸甲酯。使用DMF-缩醛形成脒,随后用LiCH₂CN环化,得到6,7-二烷氧基-4-氧代-1,4-二氢喹啉-3-腈,后续转化与之前相同。还制备了喹啉环3-位含有酸、酯、酰胺、甲醇和醛基的化合物用于比较,以及几种1-苯胺基-6,7-二甲氧基异喹啉-4-腈。评估了这些化合物抑制EGF-R催化结构域自身磷酸化的能力。研究了这些抑制剂在6,7-烷氧基基团性质、苯胺取代基以及3-位取代基方面的构效关系。进一步评估了这些化合物抑制过表达EGF-R或HER-2的细胞系生长的能力。发现4-苯胺基喹啉-3-腈是EGF-R激酶的有效抑制剂,其活性与基于4-苯胺基喹唑啉的抑制剂相当。基于Hck和FGF受体-1激酶的X射线结构构建了EGF-R激酶的新同源模型。该模型表明,对于基于喹唑啉的抑制剂,N3原子与一个水分子形成氢键,该水分子进而与Thr 830相互作用。有人提出喹啉-3-腈以类似方式结合,其中水分子被与相同Thr残基相互作用的氰基取代。